Search

Your search keyword '"Wyeth -- Mergers, acquisitions and divestments"' showing total 22 results
Start Over Descriptor "Wyeth -- Mergers, acquisitions and divestments" Publisher dow jones publishing co. (europe)
22 results on '"Wyeth -- Mergers, acquisitions and divestments"'

1. SEC probes deals, seeks inside trading

Author

Strasburg, Jenny and Scannell, Kara

Subjects
United States. Securities and Exchange Commission -- Investigations, Pfizer Inc. -- Mergers, acquisitions and divestments, Pfizer Inc. -- Investigations, Wyeth -- Investigations, Wyeth -- Mergers, acquisitions and divestments, Merck & Company Inc. -- Investigations, Merck & Company Inc. -- Mergers, acquisitions and divestments, Schering-Plough Corp. -- Investigations, Schering-Plough Corp. -- Mergers, acquisitions and divestments, Abbott Laboratories (Abbott Park, Illinois) -- Investigations, Abbott Laboratories (Abbott Park, Illinois) -- Mergers, acquisitions and divestments, Advanced Medical Optics Inc. -- Investigations, Advanced Medical Optics Inc. -- Mergers, acquisitions and divestments, Eli Lilly and Co. -- Investigations, Eli Lilly and Co. -- Mergers, acquisitions and divestments, ImClone Systems Inc. -- Investigations, ImClone Systems Inc. -- Mergers, acquisitions and divestments, Insider trading in securities -- Investigations, Company legal issue, Company acquisition/merger, Banking, finance and accounting industries, Business, Business, international
Abstract

The U.S. Securities and Exchange Commission is investigating at least nine possible violations of insider-trading laws related to recent mergers and acquisitions. Among others, the following transactions are being investigated: Pfizer Inc.'s takeover of Wyeth Corp., Merck & Co.'s purchase of Schering-Plough Corp., Abbott Laboratories' acquisition of Advanced Medical Optics, and Eli Lilly & Co.'s purchase of ImClone Systems Inc.

Published
2009

2. Pfizer outlines post-Wyeth R&D structure: company splits research on traditional drugs from biologics and strives to retain scientists

Author

Johnson, Avery

Subjects
Pfizer Inc. -- Planning, Pfizer Inc. -- Mergers, acquisitions and divestments, Pfizer Inc. -- Reorganization and restructuring, Pfizer Inc. -- Officials and employees, Wyeth -- Planning, Wyeth -- Mergers, acquisitions and divestments, Wyeth -- Reorganization and restructuring, Wyeth -- Officials and employees, Pharmaceutical industry, Company business planning, Company acquisition/merger, Company restructuring/company reorganization, Company organization, Banking, finance and accounting industries, Business, Business, international
Abstract

Pfizer Inc.'s plans to restructure Wyeth's research-and-development department call for Pfizer's R&D chief Martin Mackay to head the small-molecule research unit, and Wyeth's R&D chief Mikael Dolsten to lead the biologics unit of the integrated companies. Emilio Emini will be appointed chief scientific officer at Pfizer's vaccines unit, while Menelas Pangalos will be appointed head of the neuroscience department. The combined companies will have an annual research budget of over $10 billion.

Published
2009

3. Pfizer nears giant drug deal

Author

Karnitschnig, Matthew and Rubenstein, Sarah

Subjects
Pfizer Inc. -- Planning, Pfizer Inc. -- Mergers, acquisitions and divestments, Pfizer Inc. -- Finance, Pfizer Inc. -- Securities, Pfizer Inc. -- Company forecasts, Pfizer Inc. -- Product development, Wyeth -- Planning, Wyeth -- Mergers, acquisitions and divestments, Wyeth -- Securities, Wyeth -- Company forecasts, Wyeth -- Product development, Pharmaceutical industry, Company business planning, Company acquisition/merger, Company financing, Company securities, Company business forecast/projection, Banking, finance and accounting industries, Business, Business, international
Abstract

Pfizer Inc. is negotiating the acquisition of rival Wyeth in a deal valued at between $65 billion and $70 billion, or $50 per Wyeth share at a 30% premium on Wyeth's Thursday price. Having already procured $25 billion in bank financing, Pfizer plans to pay for two-thirds of the total in cash and the rest through the sale of stocks. Article discusses Pfizer and Wyeth's share value, debt, liquidity, capital expenditures, and development of new drugs.

Published
2009

4. BASF beats out competition to buy Cyanamid of U.S

Author

Moore, Stephen D. and Deogun, Nikhil

Subjects
BASF AG -- Mergers, acquisitions and divestments, Wyeth -- Mergers, acquisitions and divestments, Chemical industry -- Mergers, acquisitions and divestments, Pesticides industry -- Mergers, acquisitions and divestments, Banking, finance and accounting industries, Business, Business, international
Abstract

BASF AG has reached an agreement to acquire the agricultural products operations of American Home Products Corp. for $3.8 billion (3.9 billion euros). BASF outbidded other rivals for the operations.

Published
2000

5. BASF moves closer to Cyanamid deal

Author

Moore, Stephen D., Langreth, Robert, and Deogun, Nikhil

Subjects
BASF AG -- Mergers, acquisitions and divestments, Wyeth -- Mergers, acquisitions and divestments, American Cyanamid Co. -- Mergers, acquisitions and divestments, Chemical industry -- Mergers, acquisitions and divestments, Pharmaceutical industry -- Mergers, acquisitions and divestments, Pesticides industry -- Mergers, acquisitions and divestments, Banking, finance and accounting industries, Business, Business, international
Abstract

BASF AG is closer to acquiring American Home Products Corp.'s Cyanamid division. BASF would acquire the agricultural products unit for $3.8 billion (3.91 billion euros).

Published
2000

6. Speaking now: Pfizer tries to snatch Warner-Lambert from rival AHP; record $82.4 billion bid is aimed at a cash cow and a research bull; letters fall on deaf ears

Author

Lipin, Steven, Langreth, Robert, Winslow, Ron, and Harris, Gardiner

Subjects
Pfizer Inc. -- Mergers, acquisitions and divestments, Warner-Lambert Co. -- Mergers, acquisitions and divestments, Wyeth -- Mergers, acquisitions and divestments, Pharmaceutical industry -- Mergers, acquisitions and divestments, Banking, finance and accounting industries, Business, Business, international
Abstract

Pfizer Inc launched a hostile takeover of Warner-Lambert Inc for $82.4 billion after Warner-Lambert signed a $72 billion merger agreement with American Home Products Corp. Pfizer is interested in increasing its research and development budget as well as Warner-Lambert's drug, Lipitor.

Published
1999

7. Potent brew: blending of AHP and Warner-Lambert signals deals ahead; European drug companies are seen following path of $70 billion transaction; stocking empty cupboards

Author

Waldholz, Michael, Tanouye, Elyse, Harris, Gardiner, Langreth, Robert, Deogun, Nikhil, and Lipin, Steven

Subjects
Wyeth -- Mergers, acquisitions and divestments, Warner-Lambert Co. -- Mergers, acquisitions and divestments, Pfizer Inc. -- Mergers, acquisitions and divestments, Pharmaceutical industry -- Mergers, acquisitions and divestments, Banking, finance and accounting industries, Business, Business, international
Abstract

Warner-Lambert and American Home Products are expected to merge in a $70 billion agreement. This merger is the latest major merger in the pharmaceutical industry.

Published
1999

9. American Home's deal with Monsanto falls apart

Author

Burton, Thomas, Tanouye, Elyse, and Langreth, Robert

Subjects
Wyeth -- Mergers, acquisitions and divestments, Monsanto Co. -- Mergers, acquisitions and divestments, Pharmaceutical industry -- Mergers, acquisitions and divestments, Banking, finance and accounting industries, Business, Business, international
Published
1998

11. SmithKline and American Home confirm having talks on merger

Author

Moore, Stephen D. and Lipin, Steven

Subjects
SmithKline Beecham PLC -- Mergers, acquisitions and divestments, Wyeth -- Mergers, acquisitions and divestments, Pharmaceutical industry -- Mergers, acquisitions and divestments, Banking, finance and accounting industries, Business, Business, international
Published
1998

12. American Home Products buys rest of biotech firm

Subjects
Wyeth -- Mergers, acquisitions and divestments, Genetics Institute Inc. -- Mergers, acquisitions and divestments, Biotechnology industry -- Mergers, acquisitions and divestments, Health care industry -- Mergers, acquisitions and divestments, Banking, finance and accounting industries, Business, Business, international
Published
1996

13. Britain's Smith & Nephew will acquire U.S.-based Acufex for $141 million

Subjects
Smith & Nephew PLC -- Mergers, acquisitions and divestments, Acufex Microsurgical Inc. -- Mergers, acquisitions and divestments, Wyeth -- Mergers, acquisitions and divestments, Surgical equipment and supplies industry -- Mergers, acquisitions and divestments, Banking, finance and accounting industries, Business, Business, international
Published
1995

14. Colgate announces purchase of Kolynos

Subjects
Colgate-Palmolive Co. -- Mergers, acquisitions and divestments, Wyeth -- Mergers, acquisitions and divestments, Kolynos -- Mergers, acquisitions and divestments, Toiletries industry -- Mergers, acquisitions and divestments, Banking, finance and accounting industries, Business, Business, international
Published
1995

15. American Home agreement clears way to Cyanamid pact

Author

Novak, Viveca and Tanouye, Elyse

Subjects
Wyeth -- Mergers, acquisitions and divestments, American Cyanamid Co. -- Mergers, acquisitions and divestments, Pharmaceutical industry -- Mergers, acquisitions and divestments, Antitrust law -- Cases, Banking, finance and accounting industries, Business, Business, international
Published
1994

16. In takeover of Cyanamid, its shareholders are winners, but employees stand to lose

Author

Tanouye, Elyse and Steinmetz, Greg

Subjects
American Cyanamid Co. -- Mergers, acquisitions and divestments, Wyeth -- Mergers, acquisitions and divestments, Pharmaceutical industry -- Mergers, acquisitions and divestments, Banking, finance and accounting industries, Business, Business, international
Published
1994

17. American Home Products agrees to buy American Cyanamid for $9.7 billion in cash

Author

Steinmetz, Greg and Tanouye, Elyse

Subjects
Wyeth -- Mergers, acquisitions and divestments, American Cyanamid Co. -- Mergers, acquisitions and divestments, Pharmaceutical industry -- Mergers, acquisitions and divestments, Banking, finance and accounting industries, Business, Business, international
Published
1994

18. American Home raises bid for American Cyanamid

Subjects
Wyeth -- Mergers, acquisitions and divestments, American Cyanamid Co. -- Mergers, acquisitions and divestments, Pharmaceutical industry -- Mergers, acquisitions and divestments, Banking, finance and accounting industries, Business, Business, international
Published
1994

19. Cyanamid may not find a white knight

Author

Tanouye, Elyse, Steinmetz, Greg, and Moore, Stephen D.

Subjects
American Cyanamid Co. -- Mergers, acquisitions and divestments, Wyeth -- Mergers, acquisitions and divestments, Pharmaceutical industry -- Mergers, acquisitions and divestments, Corporate anti-takeover measures -- Usage, Banking, finance and accounting industries, Business, Business, international
Published
1994

20. Cyanamid tells investors to wait for review of bid

Author

Steinmetz, Greg, Tanouye, Elyse, Ingrassia, Lawrence, and Whitney, Glenn

Subjects
American Cyanamid Co. -- Mergers, acquisitions and divestments, Wyeth -- Mergers, acquisitions and divestments, Pharmaceutical industry -- Mergers, acquisitions and divestments, Banking, finance and accounting industries, Business, Business, international
Published
1994

21. American Home Products launches offer for Cyanamid

Author

Steinmetz, Greg and Tanouye, Elyse

Subjects
Wyeth -- Mergers, acquisitions and divestments, American Cyanamid Co. -- Mergers, acquisitions and divestments, Pharmaceutical industry -- Mergers, acquisitions and divestments, Banking, finance and accounting industries, Business, Business, international
Published
1994

22. American Home Products bids for American Cyanamid

Subjects
Wyeth -- Mergers, acquisitions and divestments, American Cyanamid Co. -- Mergers, acquisitions and divestments, Pharmaceutical industry -- Mergers, acquisitions and divestments, Banking, finance and accounting industries, Business, Business, international
Published
1994

Catalog

Books, media, physical & digital resources
See catalog results